Rosco, Inc. v. Safety Vision, LLC

District Court, S.D. New York·Decided August 24, 2020·No. 1:19-cv-08933·Unknown

Opinion

manatt Direct Dial: (212) 790-4520 E-mail: RHartunian@manatt.com

August 24, 2020 VIA ECF The Honorable Jesse Furman United States District Court Southern District of New York 40 Centre Street, Room 2202 New York, NY 10007 Re: Joint Letter Motion forOrder Approving Redactions Individual Practice 7(C) in Rosco v. Safety Vision, No. 19-cv-8933 Dear Judge Furman: The parties in the above-referenced matter write jointly pursuant to Individual Practice 7(C) in support of an order permitting redaction of the transcripts of the depositions of Brandon Blood and Bruce Smith pursuant to the parties’ stipulated protective order (Doc. 67). The parties agree that an order regarding redaction is appropriate, but disagree regarding its scope. Plaintiff Rosco, Inc. (Rosco) does not believe that any portion of either deposition requires redaction, but does not object to the designation by Safety Vision, LLC (“Safety Vision”), for the purposes of the pending motion, of certain sections of each deposition as “Highly Confidential.” Safety Vision, LLC seeks to have other sections of each deposition redacted. Because the supplemental motions are due tomorrow, Tuesday, August 25, (Doc. 55), the parties set forth their respective positions in this joint letter rather than by filing a letter and a response. The parties met and conferred on August 21, 2020, and significantly narrowed the scope of redactions sought. The full transcripts of the depositions are being filed under seal along with this letter as Exhibit A and Exhibit B.1 Rosco’s Position At the conclusion of each deposition, Safety Vision designated the entire deposition “highly confidential.” (Blood Transcript at 103:21–104:11; Smith Transcript at 115:5–22) After the depositions, the parties met and conferred, and Safety Vision agreed to limit its designation to “any competitive information regarding the sales database, identity of Safety Vision customers, the number of customers in various regions, and any specifics regarding SV’s sales strategy, which would be highly confidential.” (Exhibit C) The parties met and conferred after 1Only a rough transcript of the Blood deposition is currently available and that is what is being filed. The Honorable Jesse Furman August 24, 2020 Page 2 the Smith deposition, and Safety Vision stated that it would limit its “highly confidential” designations regarding that deposition to the ownership structure of certain Latin American affiliates of Safety Vision and the internal organization of Safety Vision outside of the sales force. (Exhibit D) Rosco believes that no material in either deposition is HIGHLY CONFIDENTIAL, defined as material which “if disclosed to another Party or non-party would create a substantial adverse impact on the producing Party’s business, financial condition, ability to compete, standing in the industry, or any other risk of injury that could not be avoided by less restrictive means.” (Doc. 67 at 2) Rosco does not believe that any material in either deposition qualifies as CONFIDENTIAL, which is defined as information that “qualifies for protection under standards developed under Rule 26(c) of the Federal Rules of Civil Procedure as non-public confidential and/or proprietary information.” (Doc. 67 at 2) While there may be occasion to designate material as CONFIDENTIAL or HIGHLY CONFIDENTIAL during the merits phase of this patent matter, no testimony regarding venue is sufficiently confidential to overcome the presumption in favor of disclosure. See Lugosch v. Pyramid Co. of Onondaga, 435 F.3d 110, 119–20 (2d Cir.2006). Nevertheless, in an effort to resolve this dispute, Rosco agrees that an order permitting redaction of the following sections of the depositions would be appropriate: 1) The name of Safety Vision’s database (Blood 10:4) 2) Blood’s credit card reimbursements (Blood Exhibit 10, attached as Exhibit E hereto under seal) 3) The ownership structure of the Latin American entities (Smith 37:2-39:13) Rosco has written, pursuant to Section 11 of the confidentiality order, to contest the designations. Given the short time frame before filing the briefs, it also submits this joint letter seeking an order providing for limited redactions. A broader order sought by Safety Vision—for example, redacting customer names, even though Safety Vision advertises its customers on its website (see, e.g., http://www.safetyvision.com/boyertown-area-school-district-implements- safety-visions-camera-system-school-buses-ensure-student)—would be wholly inappropriate. The “burden of demonstrating that a document submitted to a court should be sealed rests on the party seeking such action.” DiRussa v. Dean Witter Reynolds Inc., 121 F.3d 818, 826 (2d Cir. 1997), citing U.S. v. Amodeo, 71 F. 3d 1044, 1047 (2d Cir. 1995). Safety Vision has not even tried to meet this burden. Safety Vision claims that the names and titles of employees are “highly confidential” even though a simple internet search shows that these employees identify themselves by name and title at Safety Vision on their professional social media profiles. It seeks to shield questions about hiring strategy which shouldn’t even arguably be at issue. (see, The Honorable Jesse Furman August 24, 2020 Page 3 e.g., Smith Depo Tr. at 87:16-25) It also seeks to designate as “highly confidential” testimony about its vertical “sales strategy” (see, e.g., Smith Depo Tr. at 23:9–25:24; 88:16-24) even though 1) Safety Vision’s public website clearly describes that strategy in separate web pages for each vertical industry sector, or 2) the information was so “high level” as to reveal nothing even arguably confidential (see, e.g., Smith Depo Tr. at 93:3–94:4). The testimony about proprietary software revealed nothing because Mr. Smith claimed to know little about it. (Smith Depo. Tr. at 90:8–91:11); indeed Safety Vision’s publicly disseminated sales brochures explain more about this software than Mr. Smith did [See Exhibit F (Exhibit 7) to the deposition of Brandon Blood, at 3–4] Safety Vision also claims that lines of questioning went beyond the limited scope of the deposition, but Safety Vision’ counsel objected to many of these questions when they were posed, and those objections are preserved. Rosco notes a key factor in the relevant inquiry—so important that it was included in the 30(b)(6) deposition notice—is “the alleged place of business of the defendant in the district in comparison with that of other places of business of the defendant in other venues” In re Cray Inc., 871 F.3d 1355, 1364 (Fed. Cir. 2017). In any event, whether the questions were properly within the scope of the deposition is a different question than whether the responses were highly confidential sufficient to merit redaction. Finally, it claims these designations are appropriate because Rosco “recruited” a Safety Vision employee. This is not true. The employee in question, John Marlow, left Safety Vision in April 2017, worked for another company until the summer of 2019, and only joined Rosco after that. Safety Vision’s Position As stated in Rosco’s position, the parties have met-and-conferred to limit and narrow down the highly confidential designations in the depositions of Safety Vision’s employees. Those depositions took place on August 17 and 18 last week, and the parties are still waiting on the official transcript of one of the depositions.

Free access — add to your briefcase to read the full text and ask questions with AI

Rosco, Inc. v. Safety Vision, LLC, (S.D.N.Y. 2020).

Rosco, Inc. v. Safety Vision, LLC (Rosco, Inc. v. Safety Vision, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Amodeo
71 F.3d 1044 (Second Circuit, 1995)
Lugosch v. Pyramid Co. of Onondaga
435 F.3d 110 (Second Circuit, 2006)
In Re: Cray Inc.
871 F.3d 1355 (Federal Circuit, 2017)
DiRussa v. Dean Witter Reynolds Inc.
121 F.3d 818 (Second Circuit, 1997)